When testing new treatments, drugmakers must show that their formulation bears out better results than a placebo in clinical trials. In fact, the new drug must outperform the placebo by a ...
Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.
The increasing concern about the role of p values in science has gone from a murmur to a loudly expressed concern. Is this just an insider's argument or is it a matter we should take seriously?